Condition: Advanced Solid Tumor · Sponsor: Daiichi Sankyo
This study will evaluate the safety and efficacy of DS-1103a combination therapy in participants with advanced solid tumors.
This description comes directly from the study's public registry record.
Contact for Clinical Trial Information · 908-992-6400 · CTRinfo@dsi.com
Always discuss trial participation with your own doctor first.
| Florida Cancer Specialists | Sarasota, Florida, United States | Recruiting |
| Lifespan Cancer Institute | Providence, Rhode Island, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
| NEXT Oncology | Fairfax, Virginia, United States | Recruiting |
| Princess Margaret Cancer Centre, University Health Network | Toronto, Canada | Recruiting |
| Oncopole - Institut Claudius Regaud | Toulouse, Haute Garonne, France | Active Not Recruiting |
| Centre Léon Bérard | Lyon, Rhone, France | Active Not Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05765851